Monitoring Results of State Procurement of ARV Drugs in the Russian Federation in 2022
The main purpose of this document is to support efforts to fight the HIV epidemic in Russia.
Topics: Access to medicines
The main purpose of this document is to support efforts to fight the HIV epidemic in Russia.
Topics: Access to medicines
Our 20 Year Anniversary Special Edition not only reflects where have come from, but who we are; it showcases our 2022 work and shares our vision for the work ahead.
Topics: Access to medicines, Community monitoring, Differentiated service delivery
The report assesses and provides detailed information on the availability and affordability of COVID-19 vaccines from Oxford/AstraZeneca, Johnson and Johnson (J & J), Moderna, and Pfizer/BioNTech, covering 17 MICs where our Make Medicines Affordable (MMA) campaign partners work. The information they gathered covers vaccine supply, delivery, donations, pricing and technology transfer during the period between 1 January 2021 and 19 January 2022.
Topics: Access to medicines, COVID-19
A report from the United States prepared as Part of a Global and Country-Level Analysis in 18 Countries.
Topics: Access to medicines, Community monitoring, COVID-19
This publication aims to contribute to the efforts undertaken in the fight against the HIV epidemic in Russia.
Topics: Access to medicines
Assessing progress on access to COVID-19 tools across 14 countries: Bangladesh, Democratic Republic of the Congo, Haiti, Jamaica, Liberia, Madagascar, Nepal, Nigeria, Perú, Senegal, Somalia (and de facto state Somaliland), Uganda and Ukraine.
Topics: Access to medicines, COVID-19
As featured at #AIDS2022.
Topics: Access to medicines, Community monitoring
This report highlights the last year of work under our 2021-2023 Strategic Plan. It summarizes our successes, challenges, and operational capacity in 2021, and shows what investing in communities can do.
Topics: Access to medicines, Community monitoring, COVID-19
COVID-19 amplified crises across health, human rights and socio-economic domains worsening conditions for PLHIV in Uganda.
Topics: Access to medicines, Community monitoring, COVID-19
COVID-19 devastated some HIV and TB services while galvanizing others.
Topics: Access to medicines, Community monitoring, COVID-19
This Strategic Framework outlines the key reasons why a global strategy to address CM deaths is needed and what essential programmatic elements are required to make this a reality.
Topics: Access to medicines
ITPC’s 2019 Global Survey on Access to and Quality of HIV Treatment and Care, focused on barriers to quality HIV care and treatment services across 14 low- and middle-income countries. This brief summarizes findings of our peer-led research focusing on Vietnam and Indonesia.
Topics: Access to medicines
While the two countries are vastly differents, both were ruled by conservative governments when the pandemic began. This report attempts to synthesise learnings from the difference in results and response between both countries.
Topics: Access to medicines, COVID-19
The objective of this report was to conduct an in-depth examination of key features of the Brazilian response from January through to August 2020.
Topics: Access to medicines, COVID-19
This brief summarizes findings of our peer-led research focusing on two countries in Eastern Europe and Central Asia (EECA) region: Kyrgyzstan and Ukraine.
Topics: Access to medicines, Treatment education
This report summarizes findings of our peer-led research focusing on four countries in the East and Southern Africa region: Kenya, Uganda, Zambia and Zimbabwe.
Topics: Access to medicines, Differentiated service delivery, Treatment education
This report summarizes findings of our peer-led research focusing on two countries in the Middle East and North Africa region: Lebanon and Morocco.
Topics: Access to medicines, Differentiated service delivery, Treatment education
Results from a community-based participatory rapid assessment of the effects of the Covid-19 pandemic on women living with HIV and using drugs in Nepal.
Topics: Access to medicines, Community monitoring, COVID-19
A focus on contraceptive rights, inclusion, access, research in the context of HIV. Women’s ability to decide when and if...
Topics: Access to medicines, Treatment education
All countries must act NOW to make an effective COVID-19 treatment affordable for everyone.
Topics: Access to medicines, COVID-19
This Question and Answer document on COVID-19, HIV and antiretrovirals was published by the World Health Organisation Department of Global...
Topics: Access to medicines, COVID-19, Treatment education
This joint policy brief outlines how patents, and their effect on the cost of HIV treatment, threatens to undermine the HIV response in middle-income countries.
Topics: Access to medicines